Herpes Simplex Virus

Gene Therapy Disables HSV-1’s Uracil-DNA Glycosylase and Protects against Encephalitis

A viral vector delivering a uracil glycosylase inhibitor restores APOBEC1’s antiviral editing to block HSV-1 replication in the brain.